Gilead Sciences Inc buy Morgan Stanley
Start price
11.03.25
/
50%
€105.60
Target price
11.03.26
€119.76
Performance (%)
26.59%
Price
13.02.26
€130.52
Summary
This prediction is currently active. The prediction currently has a performance of 26.59%. Dividends of €3.16 are taken into consideration when calculating the performance. This prediction currently runs until 11.03.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Gilead Sciences Inc | 1.147% | 1.147% |
| iShares Core DAX® | 1.927% | -2.112% |
| iShares Nasdaq 100 | -0.184% | -5.899% |
| iShares Nikkei 225® | 7.076% | 6.457% |
| iShares S&P 500 | -0.201% | -3.667% |
Comments by Morgan_Stanley for this prediction
In the thread Gilead Sciences Inc diskutieren
Gilead Sciences, Inc. (NASDAQ: GILD) had its price target raised by analysts at Morgan Stanley from $123.00 to $130.00. They now have an "overweight" rating on the stock.
Ratings data for GILD provided by MarketBeat
Stopped prediction by Morgan_Stanley for Gilead Sciences Inc
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€105.14
13.01.26
13.01.26
€128.66
13.01.27
13.01.27
24.14%
13.02.26
13.02.26
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€104.14
12.12.25
12.12.25
€128.70
12.12.26
12.12.26
26.09%
13.02.26
13.02.26
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€105.14
31.10.25
31.10.25
€127.04
31.10.26
31.10.26
24.89%
13.02.26
13.02.26
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€91.07
25.04.25
25.04.25
€118.99
25.04.26
25.04.26
45.92%
13.02.26
13.02.26
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€87.65
10.01.25
10.01.25
€110.16
10.01.26
10.01.26
17.54%
11.01.26
11.01.26